BioCentury
ARTICLE | Top Story

Cephalon in CNS deal with Novartis in U.K.

November 27, 2000 8:00 AM UTC

CEPH and Novartis (NVS; SWX:NOVN) established a marketing collaboration in the U.K. covering five products to treat central nervous system (CNS) disorders. CEPH will exclusively market four NVS produc...